Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05322772
Other study ID # Soh-Med-22-03-05
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date April 2022
Est. completion date April 2023

Study information

Verified date April 2022
Source Sohag University
Contact Eman A Sadek
Phone 01156556464
Email eman011064@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Convulsion is a common pediatric disorder and there is strong relation between convulsion and cardiovascular system which revealed by ECG monitoring and there are many ECG abnormalities attributed to different causes of convulsions, A 12-lead ECG is a low-cost test and can detect clinically significant abnormalities such as long QTc interval or heart block. Doing an ECG in all patients presenting with seizures clinic, inevitably, pick up non-specific abnormalities which require further investigation. Moreover, a normal 12-lead ECG does not exclude a cardiovascular cause for collapse and for those in whom a cardiac cause is still suspected despite a normal ECG, referral to a cardiologist is advisable


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date April 2023
Est. primary completion date April 2023
Accepts healthy volunteers
Gender All
Age group 1 Month to 18 Years
Eligibility Inclusion Criteria: - All children aged from 1month to 18 years presenting to the Pediatric Emergency with convulsions will be included. Exclusion Criteria: - Children not filling the criteria of convulsions (like conditions mimic epilepsy) - Children with known cardiac disease or cardiac arrhythmia and patients who will not give consent will be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ECG
ii. 12 leads ECG: 12 leads ECG will be done to all infants & children using (FUKUDA DENSHI, CARDIMAX, model FCP 7101). The electrocardiograms will be reviewed through the creation of descriptive reports and determination of the following variables: heart rate, QRS duration, The QT interval was measured from the onset of the QRS complex to the end of the T wave, defined by the return of the terminal T wave to the isoelectric T-P baseline. When U waves were present, the end of the T wave will be taken as the nadir between the T and U waves. Then QT interval will be corrected for heart rate using Bazett's formula Interpretation of every ECG paper

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

References & Publications (3)

Huang X, Malek N, Simpson J, Kalladka D, Dunn FG, Leach JP. Winning hearts and minds: ECG reporting in the first seizure clinic. BMC Cardiovasc Disord. 2021 Jul 31;21(1):364. doi: 10.1186/s12872-021-02174-4. — View Citation

Karjalainen J, Viitasalo M. Fever and cardiac rhythm. Arch Intern Med. 1986 Jun;146(6):1169-71. — View Citation

Rijnbeek PR, Witsenburg M, Szatmari A, Hess J, Kors JA. PEDMEANS: a computer program for the interpretation of pediatric electrocardiograms. J Electrocardiol. 2001;34 Suppl:85-91. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other QTC normal values according to age and sex. one year
Primary heart rate normal values according to age and sex. one year
Secondary PR interval normal values according to age and sex. one year
See also
  Status Clinical Trial Phase
Completed NCT00456391 - The Utility of Performing Brain CT Scan in Non Trauma Patients at the Pediatric Emergency Unit N/A
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Terminated NCT00343096 - Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children. Phase 3
Completed NCT00116064 - Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions Phase 3
Completed NCT05670509 - Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures Phase 4
Completed NCT01030094 - A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy Phase 4